跳至主要内容
临床试验/CTRI/2016/04/006864
CTRI/2016/04/006864招募中2 期

An open clinical study to evaluate the safety and efficacy of septilin drops in the management of upper respiratory tract infection in infants and children

The Himalaya Drug Company0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • above age group patients having URTI signs and symptoms

排除标准

  • Those with serious Cardiovascular, Cerebro vascular, Respiratory, Liver or Renal disease or any other disorder.
  • Children with congenital abnormality.
  • Subjects with a strong history of food or drug allergy of any kind.
  • During course of treatment if the subject develops any acute illness requiring acute management, such patients will be excluded out of the study and continued with conventional treatment.

研究者

相似试验